- Home
- NIO vs ILMN Comparison
NIO vs ILMN Comparison
Compare NIO & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIO
- ILMN
- Stock Information
- Founded
- NIO 2014
- ILMN 1998
- Country
- NIO China
- ILMN United States
- Employees
- NIO N/A
- ILMN N/A
- Industry
- NIO Auto Manufacturing
- ILMN Medical Specialities
- Sector
- NIO Consumer Discretionary
- ILMN Health Care
- Exchange
- NIO Nasdaq
- ILMN Nasdaq
- Market Cap
- NIO 16.5B
- ILMN 15.3B
- IPO Year
- NIO 2018
- ILMN 2000
- Fundamental
- Price
- NIO $7.41
- ILMN $119.85
- Analyst Decision
- NIO Buy
- ILMN Hold
- Analyst Count
- NIO 9
- ILMN 15
- Target Price
- NIO $6.63
- ILMN $114.93
- AVG Volume (30 Days)
- NIO 58.8M
- ILMN 1.9M
- Earning Date
- NIO 11-19-2025
- ILMN 10-30-2025
- Dividend Yield
- NIO N/A
- ILMN N/A
- EPS Growth
- NIO N/A
- ILMN N/A
- EPS
- NIO N/A
- ILMN 4.46
- Revenue
- NIO $9,690,436,500.00
- ILMN $4,288,000,000.00
- Revenue This Year
- NIO $37.34
- ILMN N/A
- Revenue Next Year
- NIO $45.10
- ILMN $2.74
- P/E Ratio
- NIO N/A
- ILMN $26.90
- Revenue Growth
- NIO 9.28
- ILMN N/A
- 52 Week Low
- NIO $3.02
- ILMN $68.70
- 52 Week High
- NIO $8.02
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- NIO 58.38
- ILMN 69.17
- Support Level
- NIO $6.85
- ILMN $94.00
- Resistance Level
- NIO $7.33
- ILMN $101.93
- Average True Range (ATR)
- NIO 0.29
- ILMN 5.03
- MACD
- NIO 0.01
- ILMN 2.46
- Stochastic Oscillator
- NIO 91.46
- ILMN 87.56
About NIO NIO Inc. American depositary shares each representing one ordinary share
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.